Elixirr is an established, global, award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally recognised client base.
Elixirr, which was founded in 2009, accordingly considers itself “The Challenger Consultancy”, offering a wide range of expertise and capabilities, including defining strategy and driving business improvement with the aim of solving the challenges experienced by its clients. These challenges include: future-proofing against technological disruption; development and roll-out of new products, services and businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
Admission to Trading on AIM
On 9th July 2020 admission and dealings commenced in the Ordinary Shares on AIM by way of a Placing of 11,520,738 Ordinary Shares of 0.005 pence each at 217 pence per share
Reasons for the admission
The Board believes that Admission will provide a platform to enhance and diversify the business through:
- the opportunity to enter the next phase of Elixirr’s growth strategy and make selective acquisitions to complement or enhance Elixirr’s capabilities, industries, or geographical coverage;
- the alignment, by way of share participation, of all employees’ goals with those of the business, aiding retention and enhancing Elixirr’s recruitment appeal; and
- improving the visibility of Elixirr generally.
The Perivan shareholder communications team were delighted to work with finnCap who were appointed Nominated Adviser, Sole Broker and Sole Bookrunner on the 149-page admission document.
Perivan specialise in the production and publication of financial documents relating to shareholder and investor communications for quoted companies, private companies and open and closed ended funds.